Literature DB >> 20610359

Medication issues in older individuals with CKD.

Dena E Rifkin1, Wolfgang C Winkelmayer.   

Abstract

Older US adults bear a substantial burden of chronic disease and take an average of five prescription and non-prescription medications per day. Recent data suggest that over 20% of older adults have chronic kidney disease (CKD) as defined by an impaired glomerular filtration rate. These individuals often have multiple comorbidities, including diabetes, hypertension, and cardiovascular disease. Although patients with CKD may receive substantial benefits from prescribed medications, they are also at high risk for adverse drug events and polypharmacy. In this review, we outline the risks and benefits of medication use in the CKD population as a specific case within geriatric pharmacoepidemiology as a framework. 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610359     DOI: 10.1053/j.ackd.2010.03.005

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  6 in total

1.  Glomerular filtration rate in the elderly and in the oldest old: correlation with frailty and mortality.

Authors:  Alberto Montesanto; Francesco De Rango; Maurizio Berardelli; Vincenzo Mari; Fabrizia Lattanzio; Giuseppe Passarino; Andrea Corsonello
Journal:  Age (Dordr)       Date:  2014-03-25

2.  Special considerations in the management of chronic kidney disease in the elderly.

Authors:  Katharine Lana Cheung; Sandeep Soman; Manjula Kurella Tamura
Journal:  Dial Transplant       Date:  2011-06-01

Review 3.  [Strategies of age-adapted pharmacotherapy in renal failure].

Authors:  R Lenssen; A Liekweg
Journal:  Z Gerontol Geriatr       Date:  2016-07-22       Impact factor: 1.281

4.  Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD.

Authors:  Sikander Surana; Neeru Kumar; Amita Vasudeva; Gulvahid Shaikh; Kenar D Jhaveri; Hitesh Shah; Deepa Malieckal; Joshua Fogel; Gurwinder Sidhu; Sofia Rubinstein
Journal:  BMC Nephrol       Date:  2017-01-17       Impact factor: 2.388

5.  Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects.

Authors:  Edward Chong; Veena Kalia; Sandra Willsie; Peter Winkle
Journal:  J Nephrol       Date:  2014-04-04       Impact factor: 3.902

6.  Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study.

Authors:  Insa M Schmidt; Silvia Hübner; Jennifer Nadal; Stephanie Titze; Matthias Schmid; Barbara Bärthlein; Georg Schlieper; Thomas Dienemann; Ulla T Schultheiss; Heike Meiselbach; Anna Köttgen; Jürgen Flöge; Martin Busch; Reinhold Kreutz; Jan T Kielstein; Kai-Uwe Eckardt
Journal:  Clin Kidney J       Date:  2019-05-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.